🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the overall safety of nal...
Status
Completed
Location
Nephrology Associates PC
Start Date
2014-09
Trial ID
NCT02143973
Treatments Being Tested
The primary objectives of the study to evaluate the effects of two doses of...
Status
Completed
Location
Nephrology Associates PC
Start Date
2014-06
Trial ID
NCT02143648
Treatments Being Tested
To investigate the anti-pruritic efficacy and safety of Nalbuphine Extended...
Status
Completed
Location
Study Site 151
Start Date
2018-08-07
Trial ID
NCT03497975
Treatments Being Tested
This research study will evaluate the effect of hepatic impairment on the p...
Status
Completed
Location
01
Start Date
2019-06-12
Trial ID
NCT04020016
Treatments Being Tested
The primary purpose is to evaluate the safety and efficacy of NAL ER for th...
Status
Recruiting
Location
Pulmonary Specialists of The Palm Beaches
Start Date
2026-06-29
Trial ID
NCT07671911
To evaluate the postoperative analgesic effect of combined use of Naldebain...
Status
Unknown
Location
Department of Anesthesiology, Kaohsiung Medical University Hospital
Start Date
2021-07-07
Trial ID
NCT04962152
Treatments Being Tested
To evaluate the safety and tolerability of nalbuphine ER tablets in the stu...
Status
Completed
Location
09
Start Date
2019-10-29
Trial ID
NCT04030026
The primary objectives of the study are to evaluate the effects of two dose...
Status
Completed
Location
Case Western Reserve University
Start Date
2015-03
Trial ID
NCT02174419
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Nalbuph...
Status
Recruiting
Location
Dynamic Drug Advancement Ltd
Start Date
2026-06-22
Trial ID
NCT07671924
The purpose of this study is to measure the effects of a drug called nalbup...
Status
Completed
Location
001
Start Date
2018-05-29
Trial ID
NCT04018664
Treatments Being Tested